Turkish Journal of Nephrology
Original Article

Retrospective Analysis Of End Stage Renal Failure Patients Followed Up In Nephrology Department Between 2005 and 2010


Gülhane Askeri Tıp Akademisi, Aile Hekimliği, Ankara, Türkiye


Gülhane Askeri Tıp Akademisi, Nefroloji Bilim Dalı, Ankara, Türkiye


Gülhane Askeri Tıp Akademisi, Epidemiyoloji Bilim Dalı, Ankara, Türkiye

Turkish J Nephrol 2012; 21: 253-257
DOI: 10.5262/tndt.2012.1003.09
Read: 622 Downloads: 463 Published: 11 February 2019

OBJECTIVE: End stage renal failure (ESRF) is irreversible impairment of renal functions that
makes surviving impossible without dialysis or renal transplantation. In the present study, we aimed
to put forward the characteristics of end stage renal failure (ESRF) patients who were followed up by
Nephrology Department between 2005 and 2010.

MATERIAL and METHODS: This study was carried out through retrospective analysis of the records
of a total of 589 end stage renal failure patients followed up in Department of Nephrology, Gulhane
Military Medical Academy and Military Medical School between 2005 and 2010 and received dialysis
or underwent transplantation.

RESULTS: Of the patients in study group, 71.2% (334 patients) were males and 28.8% (135 patients)
were females. The percentage of the patients who had progressed to end stage renal failure was 37.6% in
20-44 age group, and 33% in 65 years and above group. There was a statistically signifi cant difference in
terms of distribution of age groups according to gender (p<0.05). Hypertension was the most common
disease in both gender among ESRF patients (45%) followed by diabetes mellitus (25.4%). Of renal
transplantations, 87 were from live donors and 48 were from cadavers. 48.3% of live donors were
composed of mothers. A total of 88 patients underwent biopsy (65 males and 23 females). FSGS was
the most common histopathologic diagnosis (29.3%)..

CONCLUSION: We put forward 5-year follow up results of our hospital for ESRF, one of the most important public health problems. Studies
should be targeted toward early diagnosis, treatment and slowing progress of renal failure in order to reduce the socioeconomic burden of this
disease in future.

EISSN 2667-4440